SOLID TUMORS (PHASE 1)
Clinical trials for SOLID TUMORS (PHASE 1) explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMORS (PHASE 1) trials appear
Sign up with your email to follow new studies for SOLID TUMORS (PHASE 1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets common Cancer-Causing gene in first human test
Disease control Recruiting nowThis is an early-stage trial testing a new oral drug called AN9025 in people with advanced solid tumors that have specific RAS gene mutations. The main goals are to find a safe dose, understand how the body processes the drug, and see if it shows any early signs of fighting the c…
Matched conditions: SOLID TUMORS (PHASE 1)
Phase: PHASE1 • Sponsor: Adlai Nortye Biopharma Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First patients to receive experimental cancer pill targeting genetic weakness
Disease control Recruiting nowThis is the first time researchers are testing the experimental drug ABSK131 in people. The study aims to find a safe dose and see if it helps control advanced cancers that have a specific genetic change called MTAP deficiency. It will enroll 266 adults with various solid tumors …
Matched conditions: SOLID TUMORS (PHASE 1)
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC